An investigation on behalf of investors of Corium International, Inc. (NASDAQ: CORI) in connection with the proposed takeover was announced .
San Diego, CA -- (SBWIRE) -- 10/18/2018 -- The acquisition of Corium International, Inc. is under investigation concerning whether the takeover is unfair to NASDAQ: CORI stockholders.
Investors who purchased shares of Corium International, Inc. (NASDAQ: CORI) and currently hold any of those NASDAQ: CORI shares have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain directors of Corium International, Inc breached their fiduciary duties owed to NASDAQ: CORI investors in connection with the proposed acquisition.
Menlo Park, CA based Corium International, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of specialty pharmaceutical products in transdermal and transmucosal delivery systems.
On October 11, 2018, Corium International, Inc. (Nasdaq: CORI) announced that it has entered into a merger agreement under which Gurnet Point Capital (GPC), a private investment firm focused on the healthcare and life sciences sectors, will acquire Corium International, Inc. (NASDAQ: CORI).. Under the terms of the merger agreement, GPC will pay $12.50 per share in cash upon the closing.
However, given that at least one analyst has set the high target price for NASDAQ:CORI shares at $13.00 per share, the investigation concerns whether the offer is unfair to NASDAQ: CORI stockholders.
In addition, given that Corium's largest stockholder, Essex Woodlands, has already entered into a support agreement to tender its shares in this transaction, the investigation concerns whether the Corium International Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
Those who are current investors in Corium International, Inc. (NASDAQ: CORI) shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels